Pharmaceutical Intermediates Suppliers & Manufacturers

Advantage Biotech is a life sciences supplier of magnetic bead consumables and nucleic acid purification kits, including DNA/RNA extraction and PCR clean-up products. The company offers a broad catalog of functionalized magnetic beads and purification kits for molecular biology research.

Allegrow Biotech is a Spanish biotechnology company developing the AimGel immunomodulation platform. Its product pipeline includes AimGel reagents for human T cell and NK cell research, AimTreg, and AimCore. The company operates a webstore and provides product resources for life science research.

Alpha Bio Tec. is a dental implant manufacturer with over 35 years of experience, offering implant solutions, prosthetic components, surgical instruments, and regenerative products. The company is part of Envista and serves dental professionals through a global distribution network.

Armor Pharma is a brand of the Savencia group's ingredients business, specializing in pharma-grade lactose excipients. It operates a purpose-built manufacturing site completed in 2014 and offers ranges such as EXCIPRESS and EXCIPURE for pharmaceutical applications. The company provides quality sourcing, traceability, and galenic technical support to customers worldwide.

Asac Pharmaceutical Immunology has been working in allergen and bacterial immunotherapy since 1986. The company operates two production plants where it manufactures skin prick tests, hyposensitising allergenic vaccines, bacterial vaccines, autovaccines, and allergenic and bacterial bulk vaccines. Its manufacturing processes comply with EU good manufacturing practices and EMA guidelines.

Barrier Biotech Limited, trading as Barrier Animal Healthcare, has been inventing and manufacturing natural equine and agricultural healthcare products since the 1980s. The company specializes in non-toxic, plant-derived products, including the first natural fly repellent, and serves both conventional and organic farming systems.

B.C.I. Pharma is a Belgian pharmaceutical company that has rebranded as Hirundo Biosciences. The company's website now redirects to hirundobio.com, which is coming soon with a fresh look and updates.

Beacon Pharmaceutical Ltd is a pharmaceutical company registered in Ireland. No website or additional public information was found to verify its operations or manufacturing activities.

BioMarin Pharmaceutical Inc. is a global biotechnology company founded in 1997 and headquartered in San Rafael, California. It develops and manufactures medicines for rare genetically defined conditions, including achondroplasia, severe hemophilia A, and lysosomal storage diseases. The company operates its own manufacturing and clinical development pipeline.

Bioprojet Biotech is a French pharmaceutical laboratory and research center based near Rennes. It designs and evaluates around a thousand molecules annually and played a key role in discovering the histamine RH3 receptor. The company develops and commercializes medicines for neurological, psychiatric, and other therapeutic areas, with an international presence in over 10 countries.

Biotech Dental is a French dental company that designs and manufactures dental implants, surgical instruments, biomaterials, and orthodontic solutions. The company offers a comprehensive range of products including implants, surgical kits, guided surgery systems, prosthetic solutions, and photobiomodulation devices. Biotech Dental serves dental professionals worldwide through its international presence and training programs.

Biotech Open Platform (BiOP) is a French CDMO/CMO specialized in precision fermentation, supporting start-ups and industrial companies in process development and production of innovative ingredients. The company operates an integrated platform from R&D to pre-industrial scale, with fermentation lines up to 11 m3 and a complete downstream processing line. Its pilot facility is undergoing ISO 22000 certification and emphasizes quality, traceability, and confidentiality.

Blackpoint Biotech plc is a UK-based biotech company specializing in repeatable, measured dosing products for medical cannabinoids. Its inhalers and sublingual sprays deliver fast-acting, accurate and consistent doses of cannabinoid formulations to help treat specific medical conditions.

Collegium Pharmaceutical is a biopharmaceutical company focused on developing and commercializing medicines for complex central nervous system (CNS) and pain conditions. The company emphasizes formulation and delivery innovation to improve patient outcomes. Headquartered in Stoughton, Massachusetts, Collegium is publicly traded and markets a portfolio of prescription products.

Cousin Biotech is a French medical device company that designs, develops, manufactures, and distributes innovative surgical implants and equipment worldwide. The company specializes in implantable textiles for applications including wall reinforcement, spine surgery, digestive surgery, and adhesion prevention. It also operates as a CDMO partner for implantable textile solutions.

DB Biotech is a Slovak biotechnology company that develops and produces rabbit clonal antibodies for immunohistochemistry, Western blot, ELISA, immunoprecipitation, and flow cytometry. The company uses a proprietary in-vitro cloning technology to generate monospecific antibodies for basic research and clinical diagnostics, and also offers custom antibody design and proteomic services.

DND Biotech S.R.L. is an Italian biotechnology company based in Pisa that develops biological solutions for the remediation of contaminated soil and groundwater. It provides biodegradation testing, metagenomic analysis, pilot plants, and produces microbial biomass and zeolites for bioaugmentation and contaminant adsorption. The company also engineers scale-up of bioremediation projects.

Double Bond Pharmaceutical International AB is a Swedish pharmaceutical company focused on redeveloping known drugs by changing their route of administration to create new formulations with reduced side effects and improved efficacy. Its pipeline targets areas of unmet medical need including brain cancer, liver cancer, and pneumonia, supported by an efficient drug delivery system.

B. Braun has been owned and run by the same family since 1839 — five generations, surviving two world wars, the Weimar hyperinflation, and the Nazi era, without ever losing control of the company. It started as a tiny pharmacy in Melsungen, a town of a few thousand people, where founder Julius Wilhelm Braun compounded medicines himself; today it is one of the world's largest medical technology companies. The company's product range covers the entire hospital supply chain: infusion pumps and IV solutions (its original specialty), syringes and needles, surgical instruments, wound care dressings, and hospital disinfectants. Braun is the global leader in several of these niches — its Braunüle IV catheters and its infusion systems are standard equipment in operating rooms and ICUs on every continent. With about 63,000 employees and annual revenue near €8.8 billion, Braun operates in 60+ countries and remains remarkably true to its roots: headquarters still in Melsungen (population 13,000), still family-owned, still reinvesting heavily in R&D. For hospitals and healthcare distributors, Braun is the dependable German supplier — not the flashiest brand, but the one whose products clinicians trust without thinking.

EJP Pharmaceutical ApS is a private pharmaceutical company based in Denmark. It is listed in the Synapse/Patsnap database with drug pipeline, patent, and clinical trial information, though no specific pipeline data is publicly posted.

emp BIOTECH GmbH is a German manufacturer of reagents and consumables for biotechnology, pharmaceutical, and medtech applications. The company produces oligonucleotide synthesis reagents, purification resins and columns, fine chemicals, and dyes and labeling reagents. It serves research and industrial customers with high-quality products and bespoke solutions.

emp Biotech GmbH is a German life sciences company that develops and manufactures high-quality purification resins, chromatography tools, fine chemicals, and specialty reagents for oligonucleotide synthesis. Its products support applications ranging from a few micrograms to industrial preparative scale, serving research and biopharmaceutical markets. The company is based in Berlin, Germany.

Eupheria Biotech GmbH is a German biotechnology company specializing in RNA interference (RNAi) products. It develops and manufactures endoribonuclease-prepared siRNAs (esiRNAs) and double-stranded RNAs for gene silencing research, including genome-scale libraries and custom RNAi triggers. The company provides research-grade reagents for applications such as functional genomics and AgroRNAi pest management studies.

Galaxy Pharmaceutical Limited is a pharmaceutical company based in Kenya. It is listed in the pharmaceutical category in the official registry. The company website is minimal and provides limited public information.

G&G Pharmaceutical Co., Ltd. is a pharmaceutical company that develops, manufactures, and distributes pharmaceutical products in Europe and exports medical products to China. The company focuses on women's health, with its marketed product Dienogest 2mg tablets authorized in Ireland and China. It operates through offices in Hong Kong, the Netherlands, and Beijing.

Giotto Biotech S.R.L. is an Italian biotechnology company specializing in the production of recombinant proteins, peptides, and custom organic synthesis. It offers services including antibody production, isotopic labeling, NMR standards, and metabolomics, supporting research in pharma and life sciences.

Grand Pharmaceutical Group Limited (stock code: 00512.HK) is a research-based international pharmaceutical enterprise specializing in pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision interventional diagnosis and treatment technology, and biotechnology. The company operates multiple global R&D centers with over 770 R&D personnel and more than 147 projects in progress. It develops and commercializes innovative pharmaceutical products, including radiopharmaceuticals and interventional devices.

Halo Pharmaceutical, Inc. is a contract development and manufacturing organization (CDMO) specializing in small molecule therapeutics. The company offers end-to-end services including formulation development, clinical supplies, commercial manufacturing, and analytical testing across solid, semi-solid, and oral liquid dosage forms. It operates cGMP facilities in Whippany, New Jersey, and Mirabel, Quebec, Canada, with plans to add sterile injectable manufacturing capabilities in 2026.

imd BIOTECH GmbH is an Austrian biotechnology company operating in the pharmaceutical sector. The company focuses on biotech-based products and solutions.

Intergel Pharmaceutical, LLC is a California-registered limited liability company based in Newport Beach, CA, incorporated in 2018. According to state filings, it is an inactive LLC owned by a manufacturer of vitamins, with International Vitamin Corporation listed as manager. The company operates in the pharmaceutical and nutritional supplement sector.

Janssen Pharmaceutical Unlimited Company is a pharmaceutical company operating as part of Johnson & Johnson's Innovative Medicine division. It develops and manufactures medicines and therapies across multiple therapeutic areas. The company is headquartered in Ireland and serves global markets.

Legere Pharmaceuticals is a US-based private label manufacturer of pharmaceutical-grade dietary supplements, creams, capsules, tablets, liquids, and injectables for physicians and clinics. With decades of experience, the company offers practice-branded nutraceuticals, IV therapy, and 503B injectables along with marketing support. Its products target weight loss, wellness, hormone replacement, dermatology, and digestive health.

Livzon Pharmaceutical Group Inc. is a comprehensive pharmaceutical group established in January 1985 and headquartered in Zhuhai, China. The company develops, manufactures, and markets a range of pharmaceutical products including tablets, injections, and biologics. It operates R&D platforms such as Livzon Microspheres and Livzon Bio, and has an expanding overseas business presence.

Medtronic's founding story is medical-device legend: in 1949, electrical engineer Earl Bakken started repairing medical equipment in a Minneapolis garage, and in 1957 — after a power outage disabled a hospital's bulky external pacemaker and a child died — he built the first battery-powered, wearable pacemaker using metronome circuits. That device launched the modern medical device industry, and the company he co-founded is now the world's largest. The product range spans nearly every medical specialty: cardiac devices (pacemakers, defibrillators, and the LINQ insertable monitors), diabetes management (insulin pumps and continuous glucose monitors), surgical robotics (the Hugo system), spinal and orthopedic implants, and minimally invasive surgical instruments. Medtronic's devices are used in virtually every hospital in the developed world, and its R&D budget of over US$2.5 billion a year keeps the pipeline full. Legally headquartered in Dublin (with operational headquarters in Minneapolis), Medtronic employs about 95,000 people and generates annual revenue near US$32 billion. Its scale makes it both the industry's benchmark and its consolidator — dozens of innovative startups have been absorbed into Medtronic's portfolio, a pattern that defines how medical technology reaches patients at scale.

Nanogrow Biotech Corporation is a US-based biotechnology company developing innovative biological treatments based on its proprietary single-domain antibody (SdAb) platform. The company focuses on targeted therapies with localized delivery, leveraging the small size, stability, and manufacturability of SdAbs for safer and more effective treatments.

Napp Pharmaceutical Group Limited is a UK-based pharmaceutical company headquartered in Cambridge. It develops and supplies innovative medicines to the NHS and healthcare professionals, with a portfolio including branded generics and specialty treatments. The company has been providing medicines to the UK since the 1920s and emphasizes ethical practices and quality.

Natac is a Spanish manufacturer of sustainable plant extracts and natural ingredients with proven health benefits. The company operates a multi-product extraction factory in Hervás, Extremadura, and an omega-3 facility, serving the nutraceutical, pharmaceutical, food, animal feed, pet nutrition, and cosmetics industries. Headquartered in Madrid, Natac distributes globally with commercial offices in the United States and Singapore.

NG Biotech is a French diagnostics company based in Guipry, France, specializing in rapid and reliable in vitro diagnostic tests. The company develops and manufactures tests for antimicrobial resistance, infectious diseases, and women's health, serving both professional and self-test markets. NG Biotech also offers custom development services for diagnostic assays.

NKGen Biotech is a clinical-stage biotechnology company developing natural killer (NK) cell therapies to restore immune function and treat disease. The company's SNK platform is designed to enhance a patient's ability to target and eliminate diseased cells. Headquartered in Santa Ana, California, NKGen Biotech advances its pipeline through clinical trials and proprietary manufacturing.

Novartis was created in 1996 by the merger of two Swiss pharmaceutical dynasties, Ciba-Geigy and Sandoz — both of which traced their roots to dye factories in the 1850s Basel chemical industry. The name was coined from the Latin 'novae artes', meaning 'new skills', signaling a fresh start for a company with an unusually deep European pedigree. The company's modern focus is prescription medicines across four therapeutic areas: cardiovascular, renal and metabolic (its heart failure drug Entresto and cholesterol treatment Leqvio); immunology (the blockbuster psoriasis and arthritis drug Cosentyx); neuroscience (the schizophrenia treatment and the Alzheimer's drug Leqembi, developed with Eisai); and oncology (the targeted cancer drugs Kisqali and Pluvicto). Its cell and gene therapy division pioneered CAR-T cancer treatments like Kymriah, which engineers a patient's own immune cells to attack tumors. Headquartered in Basel with about 76,000 employees and annual revenue near US$52 billion, Novartis has deliberately streamlined itself — selling its generics business Sandoz in 2023 and its eye care unit — to become a pure innovative medicines company. With one of the industry's deepest pipelines, the 25-year-old company built on 170-year-old roots is a pillar of the global pharma landscape.

Novo Nordisk was born from a Nordic biotech lineage that begins in 1923, when Danish Nobel laureate August Krogh returned from a US lecture tour with a license to produce insulin — making Denmark one of the first countries to treat diabetes domestically. The company formed through a 1989 merger of two Danish insulin makers, Novo and Nordisk, and spent a century perfecting one product category: diabetes care. That single-minded focus paid off spectacularly. Novo's modern pipeline produced semaglutide, marketed as Ozempic (for diabetes) and Wegovy (for obesity) — a GLP-1 drug that has become the best-selling medicine in history, with demand so explosive that Novo has outgrown its entire home country's workforce capacity. Its insulin portfolio (modern insulins and the smart pens that deliver them) still leads the world, and its obesity franchise has turned Novo into Europe's most valuable company, worth more than the entire Danish economy's GDP. Headquartered in Bagsværd, Denmark, with about 65,000 employees and annual revenue near US$34 billion, Novo is majority-owned by the Novo Nordisk Foundation — a unique structure where the charitable foundation reinvests dividends into science. The company's challenge now is keeping up with demand: it is spending billions on new factories in Denmark, France, and the US, racing to produce enough of the weight-loss drug that reshaped global pharma.

Nutri & Biotech S.R.L. is an Italian company founded in 2012 and based in the province of Modena, Emilia Romagna. It specializes in the development and commercialization of medical devices for the surgical treatment of obesity and dietary supplements for the medical management of obesity, overweight, weight control, wellness, and sports. Its supplements are notified to the Italian Ministry of Health and are formulated according to evolving scientific evidence.

OCB Pharmaceutical S.L. is a European company based in Barcelona, Spain, specializing in the production of bismuth compounds for pharmaceutical applications. It is part of the Vital Materials group and serves pharmaceutical, veterinary, and cosmetics markets, complying with major pharmacopoeias and regulatory agencies worldwide. The company emphasizes customer-oriented R&D, quality assurance, and sustainable, solvent-free processes.

Orion Pharma is a globally operating Nordic pharmaceutical company that develops, manufactures and markets human and veterinary pharmaceuticals as well as active pharmaceutical ingredients. Founded over a hundred years ago, it focuses on therapy areas including oncology, respiratory and neurological diseases, and women's health. The company is headquartered in Finland and serves markets worldwide.

Otsuka America Pharmaceutical, Inc. is a US-based pharmaceutical company and subsidiary of Otsuka Pharmaceutical. It develops and commercializes treatments in areas such as nephrology, immunology, and central nervous system disorders. The company conducts clinical trials and provides patient and professional resources.

Otsuka Pharmaceutical Co., Ltd. is a Japanese holistic healthcare company operating two core businesses: pharmaceuticals for diagnosis and treatment of diseases, and nutraceuticals including nutritional products and cosmedics. It develops and manufactures prescription drugs, consumer health products, and functional foods such as POCARI SWEAT and SOYJOY. The company is headquartered in Japan and is part of Otsuka Holdings.

Otsuka Pharmaceutical Europe Ltd. (OPEL) is the UK-based European headquarters of Otsuka Pharmaceutical, overseeing the company's pharmaceutical and nutraceutical businesses across Europe. The company focuses on addressing unresolved health issues in areas of the body and mind through innovative pharmaceutical products and clinical research. It operates in close collaboration with European affiliates and global colleagues as part of the global Otsuka organization founded in Japan in 1921.

Par Pharmaceutical Companies, Inc. is a US-based pharmaceutical manufacturer operating as Par Health. The company manufactures and delivers generic pharmaceuticals, active pharmaceutical ingredients (APIs), and sterile injectables, with 10 manufacturing sites worldwide including the largest API manufacturing facility in the US.

Par Pharmaceutical, Inc. (Par Health) is a US-based essential pharmaceutical company that manufactures and delivers quality medicines, including generics, sterile injectables, and active pharmaceutical ingredients. With over 160 years of legacy and 10 manufacturing sites worldwide, it serves patients and healthcare providers across multiple therapeutic areas and dosage forms.

PharmaEurope is a private contract manufacturer of food supplements based in the European Union, serving medium and large-sized companies. The company offers full-service production from formulation and ingredient sourcing to packaging, labeling, and regulatory documentation, with a minimum order quantity starting from 500 units. It operates an in-house team of over 80 specialists and exports to 42 countries.

PharmaOne Biosciences Inc. is a global pharmaceutical company engaged in research, formulation development, manufacturing, and export of pharmaceutical and nutraceutical formulations. The company also provides medical and surgical equipment and serves emerging markets across Central Asia, Australasia, and the Far East.

Procomcure Biotech GmbH is an Austrian life science company that develops and manufactures molecular diagnostics products, including DNA/RNA isolation kits, PCR mastermixes, and SARS-CoV-2 detection kits. The company serves PCR test kit manufacturers and molecular diagnostics laboratories with a focus on quality and performance. Their product portfolio also includes PCR consumables and next-generation sequencing reagents.

Progress Biotech B.V. is a Dutch producer of algal Omega-3 DHA ingredients for the food, nutraceutical and infant formula industries. The company was the first to supply a clear, flavorless and odorless plant-based DHA-rich algal oil globally and offers oils, powders and biomass as a B2B ingredient supplier. Its products are supported by ISO-22000 certification and Novel Food approval.

Q Biotech Corp develops the Inceptum chromatography platform, a fully disposable cartridge-based purification system for biotech and pharma laboratories. The system replaces traditional FPLC plumbing, pumps, and valves with single-use fluidic cartridges, offering fast setup and zero maintenance. The company serves academia, biotech, and pharmaceutical workflows with instruments, methods, and purification development services.

RD-Biotech is a French biotechnology CRO/CDMO founded in 2002, specializing in custom development and production services for DNA, monoclonal and recombinant antibodies, proteins, and cells. The company offers molecular biology, immunology, and cell-engineering services from R&D to GMP-grade manufacturing, supporting preclinical and clinical projects. Its capabilities include plasmid bioproduction, antibody production and characterization, recombinant protein expression, and cell line development.

Reese Pharmaceutical Company, operating as Reese Consumer Health, is a Cleveland, Ohio-based manufacturer founded in 1907 with over 120 years of experience in the OTC and supplement sectors. The company develops, manufactures, and private-labels consumer health products, including brands such as ColoTest, PinWorm, LiceGuard, and Australian Dream. It also offers co-creation and strategic partnership services for health and wellness brands.

Roche was founded in 1896 in Basel by Fritz Hoffmann-La Roche, who bet on a business model that was radical at the time: producing standardized medicines in factories instead of mixing them in pharmacies. The company's first hit was a cough syrup; its first blockbuster was a vitamin product in the 1930s; and its modern identity was forged in the 1960s with the discovery of Valium — the most prescribed drug in the world at the time. Today Roche is the world's largest biotech company and a leader in oncology: its cancer drugs — including Herceptin, Avastin, and the immunotherapy Tecentriq — have treated millions of patients, and its Hemlibra transformed hemophilia care. Uniquely among pharma giants, Roche is equally powerful in diagnostics: its cobas analyzers and PCR tests run in hospital labs worldwide, and its rapid COVID-19 tests during the pandemic made it a household name. This pharma-plus-diagnostics combination — pairing therapy with the tests that identify who needs it — is Roche's signature strategy. With about 100,000 employees and annual revenue near CHF 60 billion (US$67 billion), Roche is a majority owner of Genentech, the US biotech pioneer, giving it a deep pipeline in gene therapy and personalized medicine. Its biggest challenge is the patent cliff — several blockbusters face biosimilar competition — but its diagnostics franchise and oncology pipeline keep the Swiss giant among the world's most valuable healthcare companies.

Santen Pharmaceutical Spain SL is the Spanish subsidiary of Santen Pharmaceutical, a global pharmaceutical company specializing exclusively in ophthalmology. The company develops and provides treatments for eye diseases such as glaucoma, dry eye, eye infections, and cataracts. With over 100 years dedicated to ophthalmology, Santen focuses on protecting and preserving vision through innovative eye care products.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that researches, develops, manufactures, and commercializes vaccines for infectious diseases. Its product portfolio includes vaccines against COVID-19, hepatitis, influenza, and other diseases, distributed in China and internationally. The company operates its own R&D and manufacturing facilities and is listed on NASDAQ.

Sun Pharmaceutical Industries, Inc. is the US subsidiary of Sun Pharma, a leading global specialty generic pharmaceutical company. It develops, manufactures, and markets a diversified portfolio of generics, innovative medicines, and consumer healthcare products across multiple therapeutic areas. The company serves patients in over 100 countries with a focus on dermatology, oncology, and ophthalmology.

Taro Pharmaceutical Industries Ltd. is a pharmaceutical company that develops, manufactures, and markets affordable prescription and over-the-counter medications. It is a privately held company wholly owned by Sun Pharma, a global healthcare company. Taro Canada offers a range of generic and branded pharmaceutical products.

TLC Pharmaceutical Standards Ltd. is a Canadian company specializing in the custom synthesis of complex organic compounds for use as reference standards by the biomedical and pharmaceutical industries. It offers over 24,000 certified reference standards from stock, including active pharmaceutical ingredients, drug impurities, metabolites, and stable isotope labelled analogues. The company holds ISO 17034 and ISO 17025 accreditations and serves biotech, CRO, and pharmaceutical clients worldwide.

TOWA PHARMACEUTICAL CO.,LTD. is a Japanese pharmaceutical manufacturer specializing in generic drugs and formulation development. The company operates its own manufacturing sites for active pharmaceutical ingredients (API) and finished formulations, ensuring stable supply. It is listed on the Tokyo Stock Exchange and provides drug information sheets for its product lineup.

Ultragenyx Pharmaceutical Inc. is a US-based biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare genetic diseases. The company discovers, develops, and manufactures biologic and small-molecule products for serious unmet medical needs.

Veraxa Biotech AG is a Swiss biopharmaceutical company developing next-generation cancer therapeutics. Its pipeline is built on ADC technologies and novel antibody formats such as the BiTAC platform and BiTAC TCEs, with a lead program in clinical studies for AML. The company focuses on safer, more effective treatments with fewer side effects for patients.

Wald Biotech s.r.o. is a Czech biotechnology company based in Prague that develops innovative biotechnology solutions for human and animal health. Its core focus is proteolytic enzymes, including its Walzym product line, supported by in-house research and quality control. The company operates its own brands and research partnerships.

Xian Janssen Pharmaceutical Ltd. is the pharmaceutical subsidiary of Johnson & Johnson in China, established in 1985 as one of the first multinational pharmaceutical companies to enter the Chinese market. The company develops, introduces, and produces high-quality medicines and innovative health solutions across multiple therapeutic areas. It operates manufacturing and R&D activities in China to meet growing patient healthcare needs.

Star Pharmaceutical Limited is a Singapore-registered company in the pharmaceutical sector. No website or online content was found to verify its operations or manufacturing activities.

Novartis Pharmaceutical Manufacturing GmbH is part of Novartis, a global pharmaceutical company operating more than 30 production sites worldwide. The company focuses on producing innovative medicines across priority technology platforms.

China Pharmaceutical Company Limited, operating as Sinopharm, is a major Chinese state-owned pharmaceutical group engaged in R&D, manufacturing, and distribution of pharmaceuticals, biopharmaceuticals, traditional Chinese medicine, and medical equipment. It ranks among the Fortune Global 500 and operates over 1,600 subsidiaries with a broad healthcare, retail, and international business footprint.

Sidra Pharmaceutical Biomedical Foundation is a pharmaceutical manufacturer based in Saudi Arabia. The company is committed to quality, innovation, and delivering effective healthcare solutions worldwide.

La Jolla Pharmaceutical Company is a US-based biopharmaceutical company listed in the official registry under the pharma category. No website content was available for verification, so this assessment relies solely on registry data. It is presumed to be a legitimate pharmaceutical manufacturer pending further confirmation.

Naogen Pharma is a French radiopharmaceutical laboratory based in Nantes, operating as a Young Innovative Company (JEI). It develops and produces radiopharmaceutical drugs for nuclear medicine, with a focus on imaging in nuclear cardiology and detection of myocardial ischaemia. The company obtained Marketing Authorization from the French National Agency for the Safety of Medicines for a radiopharmaceutical drug made in Nantes.

NeXtGen Biologics is a regenerative medicine company developing wound care products based on axolotl-derived extracellular matrix technology. Its lead product, NeoMatriX, is a collagen wound matrix medical device designed for partial and full-thickness wounds. The company is headquartered in Alachua, Florida, USA.

Herbolea Biotech S.p.A. is an Italian biotechnology company that develops and licenses proprietary solventless extraction technologies for producing high-purity natural ingredients. Its technologies serve the botanical, cosmetic, food, and pharmaceutical industries, including GMP medical cannabis APIs. The company is headquartered in Sesto Fiorentino, Florence, Italy.

Neovii Biotech GmbH is a pharmaceutical company specializing in polyclonal antibody immunosuppressive therapies for organ transplantation and hematology/oncology. Its flagship product Grafalon is used to prevent transplant rejection and treat malignant diseases. The company operates globally with headquarters in Switzerland and a presence in Germany.

Generi Biotech is a Czech biotechnology company founded over 30 years ago, specializing in in vitro diagnostic (IVD) kits, PCR reagents, custom oligonucleotides and probes. The company also provides CRO services including GMP and GLP testing for diagnostics and life sciences. Its IVD products are CE-marked under IVDR and include real-time PCR kits for genetic and pharmacogenetic testing.

GeneSys Bio is a molecular diagnostics company developing a portable sample-to-result platform for rapid, sensitive, and specific detection of pathogens. Its technology targets infectious diseases in humans, animals, and the environment, including antibiotic resistance, delivering results in under an hour. The company is based in Montefiascone, Italy.

EmbryoTrans Biotech ApS is a Danish biotechnology company founded in 2013 and headquartered in Hovedstaden, Denmark. The company operates in the biomedicine and biotechnology sectors, with activities related to liquid paraffin and white oil. Its official website is etbiotech.com.

Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel cell therapies, including CAR-T treatments for hematologic malignancies and solid tumors. The company has treated over 10,000 patients and employs more than 3,000 people across the USA and Europe. It is an end-to-end cell therapy company with multiple technology platforms in its pipeline.

Cannara Biotech Inc. is a Canadian cannabis company specializing in the cultivation and sale of premium-quality cannabis products. With state-of-the-art facilities in Quebec spanning over 1,650,000 square feet, the company produces high-grade cannabis at low cost through scale and advanced cultivation techniques. It offers dried flowers, pre-rolls, and cannabis oils for both recreational and medical markets.

AstraZeneca is one of the world's largest biopharmaceutical companies, created in 1999 by the merger of Sweden's Astra AB and the UK's Zeneca Group, and headquartered in Cambridge, England. The company employs about 90,000 people and generates annual revenue of roughly US$45 billion, with three therapeutic pillars: oncology, cardiovascular/renal/metabolic disease, and respiratory & immunology.\n\nAstraZeneca's oncology franchise is anchored by Tagrisso (osimertinib) for EGFR-mutated lung cancer, Imfinzi (durvalumab) for immunotherapy, and Enhertu, a breakthrough antibody-drug conjugate developed with Daiichi Sankyo that is reshaping breast-cancer treatment. The company also built a global vaccines business through the COVID-19 pandemic, developing one of the first widely deployed vaccines with the University of Oxford, and maintains manufacturing sites across the UK, Sweden, the United States, China, and Singapore.\n\nFor pharmaceutical supply chains, AstraZeneca is a major buyer of active pharmaceutical ingredients, biologics raw materials, glass vials, and packaging, with stringent GMP standards, and its global manufacturing network creates stable, long-term procurement demand for specialty chemical and life-science suppliers.

CSL is a global biotechnology company headquartered in Melbourne, Australia, and one of the world's largest producers of plasma-derived and recombinant therapies. Founded in 1916 as the Commonwealth Serum Laboratories, CSL has grown into a USD 13 billion revenue company with operations in more than 35 countries and manufacturing facilities across Australia, the US, Europe and Asia. The company's CSL Behring division is a world leader in plasma therapies for immunology, haematology, critical care and infectious disease, while CSL Seqirus is a top global influenza vaccine manufacturer, and CSL Vifor focuses on iron deficiency and nephrology. CSL operates one of the world's largest plasma collection networks, with over 300 collection centres. For B2B buyers, CSL supplies plasma-derived therapies, vaccines and specialty pharmaceuticals to hospitals, distributors and government health programs worldwide. Its manufacturing excellence, regulatory track record and R&D pipeline make it a critical partner in the global biopharmaceutical supply chain.

KST Pharma is a Belgian pharmaceutical company listed in the official registry under the pharma category. No website or additional online information was found to verify its operations or product portfolio. Its legal registration suggests it is a real entity, but manufacturing status cannot be confirmed from available data.

Gricar Chemical Srl is an Italian nutraceutical company founded in 1970 and based in Brugherio, Monza and Brianza. It specializes in the contract manufacturing of food supplements, foods for special medical purposes, and medical devices, serving over 50 countries. The company operates a 3400+ sqm plant with 15+ production lines and holds numerous patents and certifications.

CSPC Pharmaceutical Group Limited is a Hong Kong-listed pharmaceutical company (HKEX: 01093) engaged in the research, development, manufacturing and sale of pharmaceutical products. Its portfolio covers finished drugs and bulk drugs, including NBP formulations, captopril tablets and albumin-bound paclitaxel for injection. The group operates R&D and manufacturing capabilities and reports significant revenue growth.

Corning Pharmaceutical Glass S.p.A. is a manufacturer of pharmaceutical glass packaging and technologies, producing vials, syringes, and cartridges for the pharmaceutical industry. It is part of Corning Incorporated, a global materials science company. The company focuses on advanced glass solutions for drug storage and delivery.

Chemada Fine Chemicals does not sell products off a shelf; it sells chemistry that other companies cannot easily run themselves. Since 1988 the company has operated its own plant at Nir Yitzhak in southern Israel, specializing in the custom synthesis of brominated and other halogenated organic compounds — a technical niche where the difficulty is precisely the point. The work is pharmaceutical and agrochemical intermediates, specialty bromine compounds, and custom synthesis projects, often involving multi-step organic synthesis and hazardous chemistry that requires distillation and specialized handling. Chemada operates under confidentiality for named customers, functioning as a CDMO-style partner rather than a catalogue supplier. Its value to a buyer is the ability to take a specialized reaction — bromination above all — from lab scale to commercial volume. Its clients are pharmaceutical and agrochemical companies and specialty materials producers who need complex intermediates at industrial scale and cannot or do not want to build that capability in-house. Quality control and regulatory documentation are part of the offering, not an afterthought. An enquiry here starts differently from a commodity order: share the target molecule or synthetic route, the required purity, the quantity per batch and the timeline. Confidentiality agreements are standard practice.

Bactolac Pharmaceutical Inc. is a US-based nutritional supplement manufacturer with over 25 years of experience. The company offers contract manufacturing of capsules, tablets, powders, and soft gels, along with packaging, labeling, and in-house testing services. It serves the dietary supplement, sports nutrition, and animal health markets.